• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 310C
Device Problems Material Rupture (1546); Incomplete Coaptation (2507); Material Distortion (2977)
Patient Problem Mitral Regurgitation (1964)
Event Date 07/23/2017
Event Type  Injury  
Manufacturer Narrative
Product analysis in progress.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that when this bioprosthetic valve was removed from its packaging, the cinch mechanism was loose.The physician decided to attempt to implant the device anyways.After suturing the device into place, hydrostatic tests indicated that valve did not coapt properly which caused central regurgitation.The physician checked to be sure that the sutures were not poorly placed and that there was no retracting muscle.Additionally, the physician reported that one of the valve leaflets was thickened.A decision was made to explant the device during the procedure.During explant, two leaflets of the valve ripped.A non-medtronic device was implanted.No additional adverse patient effects were reported. .
 
Manufacturer Narrative
Upon receipt at medtronic¿s quality laboratory, the holder was returned with the valve detached.Visual examination of the valve showed evidence of blood contact.Suture holes and damage (cut) was observed on the sewing ring.The valve was distorted; oval shaped, with the stent posts deflected.All leaflets were in open position.All leaflets were slightly stiff but flexible.The left cusp and non-coronary cusp exhibited tears.Other than the tears noted, the tissue characteristic was found acceptable.Due to the receipt condition of the explanted device, functional testing regarding the coaptation could not be performed and a conclusive cause of the regurgitation could not be determined.The valve holder was open and intact.There was no evidence of damage on the valve holder and/or rotor.Under magnification, the tips of the sutures were observed.The suture tips were jagged not smooth, indicating they were broken or torn rather than cut.The break surface of each tip is consistent with historical events that indicate a tension break.Necking or reduction in diameter was noted adjacent to the breaks.The rotor was removed from the valve holder intact.In order to determine whether the cinch holder was activated prior to breakage of the suture, the white rotor was removed from the blue holder.It was observed that suture was wound around the rotor.During the ratcheting process, as the rotor is turned in a clockwise direction, tension is applied on the ratcheting suture which results in the suture getting pulled into the legs of the holder to deflect the stent posts.This pull results in the suture winding around the rotor.The likely cause of the event is due to the customer over-ratcheting the cinch mechanism.Per mosaic ifu, it cautions ¿the suture used to deflect the stent posts may break if the handle is over tightened.¿ the device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.The analysis indicated that the valve was distorted.The distortion of the annular ring can potentially restrict the leaflets from fully opening and/or cause misalignment of leaflets during valve closure which may have led to regurgitation.Exactly when and how the distortion occurred cannot be determined; however, per medtronic¿s inspection procedure, each mosaic valve is inspected for distortion and this valve passed the inspection prior to release for distribution.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC MITRAL BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key6863180
MDR Text Key86070380
Report Number2025587-2017-01607
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeCO
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/13/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2021
Device Model Number310C
Device Catalogue Number310C25
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/12/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/07/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
Patient Weight68
-
-